Get started
Author

Anna Arefeva

Observed names: A. N. Arefeva, A. N. Arevefa, A.  N. Arefeva, Anna N. Arefeva, Арефьева Анна Николаевна
Institution: GEROPHARM (Russia)
ORCID: 0000-0003-3178-3581
Observed ORCID: 0000-0003-3178-3581
OpenAlex ID: A5013673782
Pharmacokinetics of first semaglutid drug in Russian Federation: results of open-label randomized clinical trial
2023 · A. N. Arefeva, V. V. Banko, et al. · Meditsinskiy sovet = Medical Council · 8
Semaglutide for the treatment of obesity: Results of two open randomized pharmacokinetic studies
2024 · S. M. Noskov, A. N. Arefeva, et al. · Meditsinskiy sovet = Medical Council · 7
Comparability of biosimilar romiplostim with originator: Protein characterization, animal pharmacodynamics and pharmacokinetics
2023 · Anna N. Arefeva, Igor E. Makarenko, et al. · Biologicals · 7
Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure
2024 · Ekaterina Koksharova, Roman Drai, et al. · Clinical Pharmacology in Drug Development · 6
Results of biosimilar assessing of insulin aspart preparations of Russian and foreign production using the hyperinsulinemic euglycemic clamp method and studying the use of a new ultra-fast-acting Russian biosimilar in pumps
2024 · E. N. Saverskaya, E. O. Koksharova, et al. · Meditsinskiy sovet = Medical Council · 2
PDF
Population Pharmacokinetic and Pharmacodynamic Modeling of Romiplostim Biosimilar GP40141 and Reference Product in Healthy Volunteers to Evaluate Biosimilarity
2024 · Igor Makarenko, Aleksandr Petrov, et al. · Clinical Pharmacology in Drug Development · 2
Pharmacokinetic and Pharmacodynamic Equivalence of Biosimilar and Reference Ultra‐Rapid Lispro: A Comparative Clamp Study in Healthy Volunteers
2025 · Sergei Noskov, Ekaterina Koksharova, et al. · Clinical Pharmacology in Drug Development · 1
Application of liquid chromatography-mass spectrometry for the determination of semaglutide in human serum in clinical pharmacokinetic studies
2024 · P. K. Karnakova, Е. S. Vetrova, et al. · Meditsinskiy sovet = Medical Council · 1
PDF
The first biosimilar of ultra-rapid insulin lispro: results of a double-blind randomised clamp study
2024 · S. M. Noskov, E. O. Koksharova, et al. · Meditsinskiy sovet = Medical Council · 1
PDF
Bioequivalence and Safety of Generic Glecaprevir/Pibrentasvir Compared to a Branded Product: A Randomized, Crossover Study in Healthy Volunteers
2024 · Sergei Noskov, Olesya Parulya, et al. · Clinical Pharmacology in Drug Development · 1
PDF
Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions
2024 · Sergei Noskov, Anna Arefeva, et al. · Clinical Pharmacology in Drug Development · 1
An Open-label Randomized Crossover Study with Adaptive Design of the Pharmacokinetics and Bioequivalence of GP30121 and Ceraxon® Corrected for Endogenous Analyte Level
2023 · A. N. Arevefa, A. R. Dorotenko, et al. · Drug development & registration · 1
PDF
Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial
2025 · Roman Drai, Gagik Galstyan, et al. · Diabetes Obesity and Metabolism
Author response for "Immunogenicity, Efficacy, and Safety of a Biosimilar Insulin Glulisine Compared With Originator in Adults with Type 1 Diabetes Mellitus: A Phase III Randomized Clinical Trial"
2025 · Roman Drai, Gagik Galstyan, et al. · Publons reviews and discussion
Author response for "Immunogenicity, Efficacy, and Safety of a Biosimilar Insulin Glulisine Compared With Originator in Adults with Type 1 Diabetes Mellitus: A Phase III Randomized Clinical Trial"
2025 · Roman Drai, Gagik Galstyan, et al. · Publons reviews and discussion
Опыт Применения Селективного Забора Крови Из Вен Надпочечников У Пациента С Первичным Гиперальдостеронизмом: Клинический Случай
2021 · Волкова Анна Ральфовна, Мозгунова Валентина Сергеевна, et al. · CyberLeninK (CyberLeninka)
Новые перспективы применения ингибиторов натрий-глюкозного котранспортёра 2 при сахарном диабете
2017 · В. К. Байрашева, Ivan Pchelin, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Препарат семаглутида для лечения ожирения: результаты двух открытых рандомизированных исследований фармакокинетики
· Носков Сергей Михайлович, Арефьева Анна Николаевна, et al. · CyberLeninK (CyberLeninka)
Первый препарат семаглутида в Российской Федерации: результаты открытого рандомизированного исследования фармакокинетики
· Арефьева Анна Николаевна, Банко Вениамин Валерьевич, et al. · CyberLeninK (CyberLeninka)
Первый биоаналог инсулина лизпро сверхбыстрого действия: результаты двойного слепого рандомизированного клэмп-исследования
· Носков Сергей Михайлович, Кокшарова Екатерина Олеговна, et al. · CyberLeninK (CyberLeninka)
Применение жидкостной хромато-масс-спектрометрии для определения семаглутида в сыворотке крови человека в клинических исследованиях фармакокинетики
· Карнакова Полина Константиновна, Ветрова Евгения Сергеевна, et al. · CyberLeninK (CyberLeninka)
Works count: 21
Citation count: 38
H-index: 4
I10-index:
Year
Topic
Type